DGMT service contract on PacBio Revio sequencer
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $250,000 to $700,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 811219 Other Electronic and Precision Equipment Repair and Maintenance
- Points of contact
-
- NCTR Acquisition Liaison nctr.acquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is forecasting a new requirement for a Diagnostic and Genomic Medicine Technology (DGMT) service contract for maintenance and support of a PacBio Revio next-generation sequencing instrument. The contract will require the contractor to provide comprehensive repair and maintenance services for this precision diagnostic equipment. The estimated solicitation release date is July 1, 2025, with an anticipated award date of January 1, 2026.
The estimated award value for this contract ranges from $250,000 to $700,000, with the contract classified under NAICS code 811219 for electronic and precision equipment repair and maintenance services. Interested contractors should direct inquiries to the FDA's National Center for Toxicological Research acquisitions team at nctr.acquisitions@fda.hhs.gov, which serves as the primary point of contact for this opportunity. This is a competitive procurement with no small business set-aside restriction.
Forecast text
DGMT service contract on PacBio Revio NGS instrument
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast